Clinical Trials Logo

Clinical Trial Summary

Evaluation of safety and performance of HA based injectable device for skin quality improvement


Clinical Trial Description

The primary objective is to evaluate the effectiveness of the device used one month (M1) after treatment using clinical evaluation of the global aesthetic improvement (GAIS) rated by an independent investigator. The secondary objectives of the study are to collect data on: - the effectiveness four months (M4) after treatment. - the effectiveness on the improvement of facial skin quality by objective measurements of skin biomechanical parameters using Cutometer® and skin hydration using Moisturemeter®. - subject's satisfaction and subject's opinion on aesthetic improvement. - the injector's satisfaction on the injection quality. - the safety using clinical evaluation of the Injection Site Reactions (ISR). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06142643
Study type Interventional
Source Kylane Laboratoires
Contact Aurélie Chateau
Phone +41225889610
Email a.chateau@kylane.com
Status Not yet recruiting
Phase N/A
Start date December 15, 2023
Completion date October 31, 2024

See also
  Status Clinical Trial Phase
Completed NCT00992277 - In-vivo Analysis and Clinical Evaluation of the Performance of a Fractional CO2 Laser System (eMatrixCO2) Phase 2/Phase 3
Recruiting NCT06142578 - Safety and Effectiveness Clinical Evaluation of Injectable Medical Devices N/A